Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1999-12-7
pubmed:abstractText
Dematin is a cytoskeletal protein that bundles actin filaments in a phosphorylation-dependent manner. The primary structure of dematin is organized into an N-terminal core domain of unknown function and a C-terminal domain that is homologous to the "headpiece" domain of villin. We have previously localized the dematin gene on human chromosome 8p21.1, a region distal to the ankyrin locus for hereditary spherocytosis. Radiation hybrid mapping now places dematin between D8S258 and D8S137, two microsatellite markers frequently deleted in prostate cancer. The 8p21.1 region is also deleted in prostate, breast, colon, and bladder cancers, suggesting the presence of a tumor suppressor gene(s). Using laser-capture microdissection technique and fluorescence in situ hybridization (FISH), we demonstrate loss of heterozygosity (LOH) of the dematin gene in a majority of chromosomal region 8p21-linked prostate tumors. One allele of dematin was also deleted in the established prostate adenocarcinoma cell line PC-3, which displays a classic oncogenic phenotype. Overexpression of wild-type dematin in PC-3 cells resulted in the restoration of a more polarized, epithelial-like phenotype. Conversely, the heterologous expression of dominant negative mutants of dematin perturbed normal cell morphology of NIH 3T3 fibroblasts. These results suggest a biological function of dematin in the regulation of cell shape, with implications in the pathobiology of prostate tumorigenesis.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0165-4608
pubmed:author
pubmed:issnType
Print
pubmed:volume
115
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
65-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:10565303-3T3 Cells, pubmed-meshheading:10565303-Animals, pubmed-meshheading:10565303-Blood Proteins, pubmed-meshheading:10565303-Chromosomes, Human, Pair 8, pubmed-meshheading:10565303-Cytoplasm, pubmed-meshheading:10565303-Cytoskeletal Proteins, pubmed-meshheading:10565303-DNA, Antisense, pubmed-meshheading:10565303-Epithelium, pubmed-meshheading:10565303-Humans, pubmed-meshheading:10565303-Loss of Heterozygosity, pubmed-meshheading:10565303-Male, pubmed-meshheading:10565303-Mice, pubmed-meshheading:10565303-Microfilament Proteins, pubmed-meshheading:10565303-Models, Genetic, pubmed-meshheading:10565303-Phenotype, pubmed-meshheading:10565303-Phosphoproteins, pubmed-meshheading:10565303-Physical Chromosome Mapping, pubmed-meshheading:10565303-Prostate, pubmed-meshheading:10565303-Prostatic Neoplasms, pubmed-meshheading:10565303-Tumor Cells, Cultured
pubmed:year
1999
pubmed:articleTitle
Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression.
pubmed:affiliation
Section of Hematology/Oncology Research, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't